Back

EMIT AF/VTE study - Discussion

19 March 2019 (08:40 - 08:45)
Organised by:
Congress Presentation Part of: Late-breaking trials 4 Oral Anticoagulation EHRA Premium Access EHRA 2019

About the speaker

Photo
Professor Jan Steffel

Klinik Hirslanden, Zurich (Switzerland)

6 More presentations in this session

Presentation thumbnail
Periprocedural edoxaban management in routine clinical practice is associated with low bleeding risk: outcomes from the prospective multicentre, multinational EMIT AF/VTE study
Professor P. Colonna (Bari, IT)
Slides Video
Presentation thumbnail
The GermAn Laser Lead Extraction RegistrY: GALLERY
Associate Professor S. Hakmi (Hamburg, DE)
Slides Video
Presentation thumbnail
GALLERY - Discussion
Doctor M. Bongiorni (San Giuliano Terme, IT)
Slides Video
Presentation thumbnail
The OPT-PACE Ttria - Optimising pacemaker and medical therapy in pacemaker patients for heart failure
Doctor M. Paton (Leeds, GB)
Slides Video
Presentation thumbnail
The OPT-PACE Trial - Discussant Review.
Professor G. Milasinovic (Belgrade, RS)
Slides Video

Access the full session

Session thumbnail
Late-breaking trials 4

The Event

Event poster

EHRA 2019

19 March 2019 08:40 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Presentation
State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources